Your browser doesn't support javascript.
loading
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study.
Ferro, Matteo; Marchioni, Michele; Lucarelli, Giuseppe; Vartolomei, Mihai D; Soria, Francesco; Terracciano, Daniela; Mistretta, Francesco A; Luzzago, Stefano; Buonerba, Carlo; Cantiello, Francesco; Mari, Andrea; Minervini, Andrea; Veccia, Alessandro; Antonelli, Alessandro; Musi, Gennaro; Hurle, Rodolfo; Busetto, Gian M; Del Giudice, Francesco; Chung, Benjamin I; Berardinelli, Francesco; Perdonà, Sisto; Del Prete, Paola; Mirone, Vincenzo; Borghesi, Marco; Porreca, Angelo; Bove, Pierluigi; Autorino, Riccardo; Crisan, Nicolae; Abu Farhan, Abdal R; Battaglia, Michele; Ditonno, Pasquale; Russo, Giorgio I; Muto, Matteo; Damiano, Rocco; Manfredi, Matteo; Porpiglia, Francesco; DE Cobelli, Ottavio; Schips, Luigi.
Afiliación
  • Ferro M; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy - matteo.ferro@ieo.it.
  • Marchioni M; Unit of Urology, Department of Medical, Oral and Biotechnological Sciences, SS. Annunziata Hospital, G. D'Annunzio University, Chieti, Italy.
  • Lucarelli G; Section of Urology, Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
  • Vartolomei MD; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, Târgu Mureș, Romania.
  • Soria F; School of Medicine, Division of Urology, Department of Surgical Sciences, Turin, Italy.
  • Terracciano D; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Mistretta FA; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy.
  • Luzzago S; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy.
  • Buonerba C; CRTR Rare Tumors Reference Center, University of Naples Federico II, Naples, Italy.
  • Cantiello F; Department of Urology, Magna Graecia University, Catanzaro, Italy.
  • Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Minervini A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Veccia A; Division of Urology, Department of Surgery, VCU Health System, Richmond, VA, USA.
  • Antonelli A; Department of Urology, University of Verona, Verona, Italy.
  • Musi G; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy.
  • Hurle R; IRCCS Humanitas Clinic, Rozzano, Milan, Italy.
  • Busetto GM; Department of Urology, Sapienza University, Rome, Italy.
  • Del Giudice F; Department of Urology, Sapienza University, Rome, Italy.
  • Chung BI; School of Medicine, Stanford University, Stanford, CA, USA.
  • Berardinelli F; Unit of Urology, Department of Medical, Oral and Biotechnological Sciences, SS. Annunziata Hospital, G. D'Annunzio University, Chieti, Italy.
  • Perdonà S; Department Uro-Gynecology, IRCCS G. Pascale Foundation, National Institute for the Study and Treatment of Cancer, Naples, Italy.
  • Del Prete P; Scientific Directorate, IRCCS G. Pascale Foundation, National Institute for the Study and Treatment of Cancer, Naples, Italy.
  • Mirone V; Unit of Urology, Department of Neurosciences, Sciences of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Borghesi M; Department of Urology, University of Bologna, Bologna, Italy.
  • Porreca A; Department of Robotic Urologic Surgery, Abano Terme Hospital, Abano Terme, Padua, Italy.
  • Bove P; Division of Urology, Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Autorino R; Division of Urology, Department of Surgery, VCU Health System, Richmond, VA, USA.
  • Crisan N; Department of Urology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Abu Farhan AR; Department of Urology, Magna Graecia University, Catanzaro, Italy.
  • Battaglia M; Section of Urology, Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
  • Ditonno P; Section of Urology, Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
  • Russo GI; Department of Urology, University of Catania, Catania, Italy.
  • Muto M; Unit of Radiotherapy, Moscati University Hospital, Avellino, Italy.
  • Damiano R; Department of Urology, Magna Graecia University, Catanzaro, Italy.
  • Manfredi M; School of Medicine, Division of Urology, Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
  • Porpiglia F; School of Medicine, Division of Urology, Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
  • DE Cobelli O; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy.
  • Schips L; Unit of Urology, Department of Medical, Oral and Biotechnological Sciences, SS. Annunziata Hospital, G. D'Annunzio University, Chieti, Italy.
Minerva Urol Nephrol ; 73(6): 796-802, 2021 12.
Article en En | MEDLINE | ID: mdl-33439571
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Minerva Urol Nephrol Año: 2021 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Minerva Urol Nephrol Año: 2021 Tipo del documento: Article Pais de publicación: Italia